Court Keeps Aciphex Free Of Generic Competition
In a 62-page opinion, Judge Gerard E. Lynch of the U.S. District Court in Manhattan said Japanese pharmaceutical company Eisai had not engaged in inequitable conduct.
“Defendants have failed to prove inequitable conduct by clear and convincing evidence, and…plaintiffs accordingly have established their claim of patent infringement,” Judge Lynch wrote.
The U.S. subsidiary of Eisai first sued India-based...
To view the full article, register now.